Bortezomib Unknown Status Phase 1 / 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01495351Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma